Sign in to view content

Diabetic Retinopathy and the MyVisionTrack App Study (DRAMA)

Samuel K. Steven Houston, MD, FASRS

Video
Published 2017

Related

Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Diabetic Macular Edema: 36-Week Results From the Phase 2 BOULEVARD Clinical Trial
Rishi P. Singh, MD
Annual Meeting Talks
2018
Cost of Initial Aflibercept, Laser, or Observation in Eyes With Diabetic Macular Edema and Good Vision Based on Management Approaches in Protocol V
Jennifer K. Sun, MD
Annual Meeting Talks
2020
Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2019

Category: Diabetic Retinopathy

See more